设为首页加入收藏
  • 首页
  • Start up
  • 当前位置:首页 >Start up >【】

    【】

    发布时间:2025-09-13 07:38:13 来源:都市天下脉观察 作者:Start up

    Latest

    AI

    Amazon

    Apps

    Biotech & Health

    Climate

    Cloud Computing

    Commerce

    Crypto

    Enterprise

    EVs

    Fintech

    Fundraising

    Gadgets

    Gaming

    Google

    Government & Policy

    Hardware

    Instagram

    Layoffs

    Media & Entertainment

    Meta

    Microsoft

    Privacy

    Robotics

    Security

    Social

    Space

    Startups

    TikTok

    Transportation

    Venture

    More from TechCrunch

    Staff

    Events

    Startup Battlefield

    StrictlyVC

    Newsletters

    Podcasts

    Videos

    Partner Content

    TechCrunch Brand Studio

    Crunchboard

    Contact Us

    AvantGuard
    Image Credits:Christine Hall, TechCrunch / AvantGuard CEO Edward “Ted” Eveleth
    Biotech & Health

    AvantGuard wants to turn chlorine into the best antiseptic you’ve ever seen

    Christine Hall 2:17 PM PDT · September 21, 2023

    When most of us think of chlorine, we imagine the chemical that keeps our pools clean and removes stains from white clothes. AvantGuard sees chlorine as a rechargeable chemical that can be turned into the ultimate surface protectant.

    AvantGuard was originally founded as Halomine in 2018 and spun out of Cornell University. It is working with N-halamines, an organic compound most commonly linking nitrogen with chlorine. When put together, it enables antibacterial capabilities — essentially a “microbial death.”

    The company licensed N-halamine technology from both Cornell and Auburn University, where it has been working on this for 30 years, according to AvantGuard CEO Edward “Ted” Eveleth, who joined the company in 2019.

    What AvantGuard is doing differently than your average chlorine-based disinfectant is that it is making a polymer version. This enables them to do “all sorts of cool and interesting things” with halamines, Eveleth told TechCrunch. Like sticking it on a surface or adding other functionalities so that no proteins will stick to it. This means it can make any surface an antimicrobial surface.

    And not just surfaces: There are dozens of uses for this polymer version, from water treatment to an ointment to treat acne, a topical antifungal and medical uses like wound dressing or a coating that will protect medical devices for months at a time. The company predicts there is more than $70 billion in potential market impact.

    The company’s initial product is a spray-on antimicrobial coating called 247. It sprays on and when left to dry leaves behind a transparent film. When used in conjunction with a chlorinated disinfectant, it binds the chlorine to the surface that doesn’t wipe off easily. It also can be sprayed on a number of different surfaces, including fabric, which is how AvantGuard will use it on wound dressings.

    “When pathogens land on the surface, it will kill the pathogens,” Eveleth said. “We’re the only product that has been able to pass the EPA (Environmental Protection Agency) testing for gram negative, gram positive and envelope viruses. We can get a 99.9% reduction within two hours as a residual antimicrobial coating, and we’re the only coating that could do that.”

    Techcrunch event

    Join 10k+ tech and VC leaders for growth and connections at Disrupt 2025

    Netflix, Box, a16z, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch, and a chance to learn from the top voices in tech. Grab your ticket before Sept 26 to save up to $668.

    Join 10k+ tech and VC leaders for growth and connections at Disrupt 2025

    Netflix, Box, a16z, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just some of the 250+ heavy hitters leading 200+ sessions designed to deliver the insights that fuel startup growth and sharpen your edge. Don’t miss the 20th anniversary of TechCrunch, and a chance to learn from the top voices in tech. Grab your ticket before Sept 26 to save up to $668.

    San Francisco | October 27-29, 2025 REGISTER NOW

    Currently, the product needs to be put on quarterly, however, Eveleth said that time frame may end up being yearly when AvantGuard gets done with all of its testing. He expects regulatory approval on 247 in early 2024.

    The company raised over $8 million in grants from the National Institutes of Health, National Science Foundation and others, and $4 million in equity.

    Meanwhile, AvantGuard is working on a strategic partnership with a medical device company and is focused on creating an antifungal product. One of its patents will also be formalized this month. The company has plans to begin raising another round of funding at the end of the year.

    “We have a proven biocide that has no history of resistance generation,” Eveleth said. “Our mission is to be your first line of defense against all pathogens on all surfaces, skin included, and reserve oral antibiotics for when we need them most.”

    5 tips for healthcare startups fundraising in a down market

    • 上一篇:Truveta's big data healthcare project is pretty cool
    • 下一篇:When it comes to startup board participation, VCs and CEOs must do their jobs

      相关文章

      • N26 adds crypto trading with new Bitpanda integration
      • Acceleron Fusion has raised $15M to take a stab at colder fusion, filing reveals
      • Support automation firm Capacity grows with new cash and acquisitions
      • Open source Lightdash gets Accel's backing to bring AI to business intelligence
      • Edtech’s honeymoon might be over, but expect a second boom
      • Shield AI’s founder on death, drones in Ukraine, and the AI weapon ‘no one wants’
      • Canoo's CFO and top lawyer are the latest executives to leave
      • How to build a company that can save the world and generate a profit
      • Dat Bike gets another $8M to put more e
      • ShoBizzy, a networking app for the TV industry, aims to open new doors for freelancers

        随便看看

      • Pittsburgh's AI expertise may give rise to an already growing startup market
      • Yelp just spent $80M on a site for car repair estimates
      • DuckDuckGo will be making more early
      • The FTC comes after neobank Dave for misleading marketing, hidden fees
      • Daily Crunch: World’s largest Black
      • SpaceX alums are working to raise a hefty $550M first deep tech fund
      • Gusto’s head of technology says hiring an army of specialists is the wrong approach to AI
      • Femtech startup Perelel is acquiring Founders Fund
      • How to respond when a VC asks about your startup’s valuation
      • Groww pays $160M tax as it returns to India amid a startup relocation wave
      • Copyright © 2025 Powered by 【】,都市天下脉观察   辽ICP备198741324484号sitemap